ImpediMed Limited (IPD) is involved in designing and manufacturing of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of tissue composition and fluid status. IPD produces a family of FDA cleared and CE Marked medical devices for multiple indications including heart failure and lymphoedema.
ImpediMed
Follow
Get notifications in MyBN when activity occurs.
Company Activity
NEW ROLE: Fiona Bones, Non-Executive Director | 31 Jul 2024 | |
NEW ROLE: Janelle Delaney, Non-Executive Director | 31 Jul 2024 | |
NEW ROLE: Christine Emmanuel, Non-Executive Director | 31 Jul 2024 | |
NEW ROLE: McGregor Grant, Executive Chairman, Executive Director, Chief Financial Officer | 31 Jul 2024 | |
NEW ROLE: Parmjot Bains, Managing Director, Chief Executive Officer | 31 Jul 2024 | |
NEW ROLE: Andrew J Grant, Non-Executive Director | 31 Jul 2024 | |
NEW ROLE: T Cruickshank, | 15 Oct 2021 | |
NEW ROLE: S Tripathi, Chief Technology Officer | 25 Nov 2020 | |
NEW ROLE: D Schlaht, SVP R&D and Technology | 25 Nov 2020 |